http://www.gsk.com/media/ GlaxoSmithKline is a leading healthcare company that helps people to do more, feel better and live longer. This RSS feed contains press releases and investor news. http://www.gsk.com/media/pressreleases/2008/2008_pressrelease_10044.htm GlaxoSmithKline welcomes the online publication in Nature of the article 'The mechanism of H5N1 Influenza resistance to Tamiflu and implications for drug stockpiles' in which the authors state "our results indicate that it would be prudent for pandemic stockpiles of oseltamivir to be augmented by additional antiviral drugs, including zanamivir." Wed, 12 May 2008 17:00:00 GMT http://www.gsk.com/media/pressreleases/2008/2008_pressrelease_10044.htm http://www.gsk.com/media/pressreleases/2008/2008_pressrelease_10043.htm Neutralising antibodies are believed by experts to be important for cervical cancer prevention Wed, 12 May 2008 09:00:00 GMT http://www.gsk.com/media/pressreleases/2008/2008_pressrelease_10043.htm http://www.gsk.com/media/pressreleases/2008/2008_pressrelease_10042.htm GSK, in collaboration with BIG, a leading academic breast cancer research network, and one of its member groups, the SOLTI, today announced the start of a global Phase III study that will examine the role of lapatinib (Tykerb®/Tyverb®) in the treatment of early breast cancer (EBC). Mon, 12 May 2008 19:45:00 GMT http://www.gsk.com/media/pressreleases/2008/2008_pressrelease_10042.htm http://www.gsk.com/media/pressreleases/2008/2008_pressrelease_10040.htm GlaxoSmithKline plc (GSK) announced today that Fountain Acquisition Corporation, a wholly-owned subsidiary of GSK, is commencing a cash tender offer to purchase all outstanding shares of common stock of Sirtris Pharmaceuticals, Inc. Fri, 02 May 2008 14:00:00 GMT http://www.gsk.com/media/pressreleases/2008/2008_pressrelease_10040.htm http://www.gsk.com/media/pressreleases/2008/2008_pressrelease_10038.htm Advair 250/50 now the only treatment approved to both reduce exacerbations and improve lung function Wed, 30 Apr 2008 21:00:00 GMT http://www.gsk.com/media/pressreleases/2008/2008_pressrelease_10038.htm http://www.gsk.com/media/pressreleases/2008/2008_pressrelease_10037.htm GSK today announced a number of changes to its Corporate Executive management team. Wed, 30 Apr 2008 15:00:00 GMT http://www.gsk.com/media/pressreleases/2008/2008_pressrelease_10037.htm http://testnew.gsk.com/media/pressreleases/2008/2008_pressrelease_10031.htm GSK announces Q1 results 2008 Wed, 23 Apr 2008 12:00:00 GMT http://testnew.gsk.com/media/pressreleases/2008/2008_pressrelease_10031.htm http://www.gsk.com/media/pressreleases/2008/2008_us_pressrelease_10038.htm GlaxoSmithKline (NYSE: GSK) and Sirtris Pharmaceuticals Incorporated (Nasdaq: SIRT) announced today that they have entered into a definitive agreement pursuant to which GlaxoSmithKline will acquire Sirtris Pharmaceuticals for approximately USD720 million (or approx. GBP362 million) through a cash tender offer of USD22.50 (or approx. GBP11.33) per share. Tue, 22 Apr 2008 21:00:00 GMT http://www.gsk.com/media/pressreleases/2008/2008_us_pressrelease_10038.htm http://www.gsk.com/media/pressreleases/2008/2008_pressrelease_10027.htm Companies announce significant microRNA therapeutics collaboration Thu, 17 Apr 2008 12:15:00 GMT http://www.gsk.com/media/pressreleases/2008/2008_pressrelease_10027.htm http://www.gsk.com/media/pressreleases/2008/2008_us_pressrelease_10034.htm Clinical studies show Treximet provided significantly more patients migraine pain relief compared to sumatriptan 85 mg Wed, 16 Apr 2008 04:00:00 GMT http://www.gsk.com/media/pressreleases/2008/2008_us_pressrelease_10034.htm